Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta - Wikidata - wikimedia - TriplyDB

Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta

Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta

http://www.wikidata.org/entity/Q34009618

about

The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease Alzheimer's disease pathologic cascades: who comes first, what drives what Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner Biochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's disease Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity Quantitative structural MRI for early detection of Alzheimer's disease.Why pleiotropic interventions are needed for Alzheimer's disease.Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.Role of metal dyshomeostasis in Alzheimer's disease.Frontiers in Alzheimer's disease therapeutics.The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations Periodontal disease associates with higher brain amyloid load in normal elderly.Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention.Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is 'too big to fail'.Cell cycle deregulation in the neurons of Alzheimer's disease.Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.Neuroendocrinology-based therapy for Alzheimer's disease.Deciphering the mechanism underlying late-onset Alzheimer disease.On the subject of rigor in the study of amyloid β-protein assembly.Regulation of protein conformation by Pin1 offers novel disease mechanisms and therapeutic approaches in Alzheimer's disease Understanding the cause of sporadic Alzheimer's disease.Evidence-based medical knowledge: the neglected role of expert opinion.Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction. Hypothetical role of the adapter protein ECSIT in familial and sporadic Alzheimer's disease pathogenesis.Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials.Computational identification of potential multi-drug combinations for reduction of microglial inflammation in Alzheimer disease.Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.The double-edged role of copper in the fate of amyloid beta in the presence of anti-oxidants.Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.Cellular hormetic response to 27-hydroxycholesterol promotes neuroprotection through AICD induction of MAST4 abundance and kinase activity.Glial Asthenia and Functional Paralysis: A New Perspective on Neurodegeneration and Alzheimer's Disease.

P2860

Q26991654-3DA9F186-C22D-4859-B5BD-30E384840216 Q26995896-05A3C481-DB51-42A4-A7AA-44A518CAD0D0 Q27015785-5E882932-A591-4FDE-9FE7-33FAE62B6EF2 Q27024824-15BF9FB2-A7D8-4213-A767-70BBBF639054 Q28476620-868AC2AF-1780-4F88-8862-4E7A02AE5D01 Q28542628-AD9AD40F-4536-4DAC-A21B-E45D87AB2CE0 Q30887483-04916B46-8133-4FE9-81C8-40F6BC901F27 Q33611723-3CE44E65-EE62-49C6-8FF7-1F3CACAB1BB2 Q33729033-C470B747-90A0-4704-96B1-7A50CB6577C9 Q33876128-6B8DBBCF-50F0-4575-AE93-F4AAFC38DA83 Q33957213-B659E6E2-5F74-4305-B5AE-10F41CE9F110 Q34191283-43AA8EDB-F0C0-4EF5-868A-8EEE176C7A0F Q34681267-B1A10936-E30B-49A5-9719-942D85B9BFC2 Q35051952-30C8A1E7-C00E-4B46-AC03-0E21CE586240 Q35086876-6393EC4E-4EA5-4E1E-B1BB-DA31C0FC71D1 Q35186712-81173629-41C6-40D9-999F-59AF31797E90 Q35447921-FE406DBF-66C6-4D46-A06D-0834E771AA2E Q35895780-F20CAA7F-2461-4164-BB32-2896981FEB25 Q35946092-0AE27704-667C-4A94-919F-CB2CB2EB3D18 Q36764094-E87D9ED6-9164-4451-80EB-A9C22D99207D Q37111847-CCB50621-4959-4922-AE08-AC21636E2710 Q37609644-5A07AED1-00F2-4E74-82D2-7A02C0A5C8F5 Q37873869-8D21CC43-AFED-4766-996A-618DE13DCB4A Q37883217-1EEBFA09-2E2B-4593-BD0D-AB50BF2EB539 Q37958200-34719454-7B68-490A-BD00-116A6B66C165 Q37984574-39B5B374-F4F5-49A9-B547-801198B06968 Q37995980-CC6912C1-E43F-4B16-BD3C-5454E282D265 Q38062817-E96AA231-9B41-46C6-A488-7302B167EDBC Q38131957-7DBF8A8C-EB9C-4440-A69F-7A93E6F7D23B Q38188732-9104E5C8-06A2-4DDF-8012-580776C98DF4 Q38213834-021E875D-C5E3-4097-9C36-435F17DC90A8 Q38255400-B9AEACF5-19DC-4E39-B910-D3BF0B70DA83 Q39627759-9EE73984-6D7C-4DE3-A3CA-324D049B10EC Q39753296-D4C906BC-2A8F-450E-9313-1976BCEF26DD Q40813292-37A413B7-D050-4383-A53C-DF68E209FD89 Q41979914-3AEB2A4D-CE7B-419E-804A-F8C2AD728B23 Q42210310-575344B4-EA44-44F0-93D1-F3EC6B2931B9 Q42281747-DB49DA1C-0E67-45D3-9F1C-D1EA52B779A0 Q42638502-E67CE283-7E26-48CC-91C7-B051D87859A9 Q43906107-39AFDDF6-3AFA-4F61-B230-64B91539EC95

P2860

Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta

http://www.wikidata.org/entity/Q34009618

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@ast

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@en

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@nl

type

label

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@ast

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@en

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@nl

prefLabel

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@ast

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@en

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@nl

P1433

Q34009618-FAAEBDA1-3257-471C-A404-639BE8634CAC

P1476

Q34009618-62FC01E8-AD77-415D-A061-B2162366882D

P2093

Q34009618-7D7E527A-3887-4C57-97B0-96E417639856

Q34009618-AEC29526-3B13-49D5-99F0-0D29B393449E

Q34009618-D19F10D8-5320-47D8-89C6-B096E227108B

Q34009618-EB40EDEE-3100-48F7-83E5-D36FBC6A0F23

Q34009618-F6506070-C9A4-4094-8F92-EC4030524481

Q34009618-FAF093A9-A3F3-4A3F-B849-A5E098DAC656

P2860

Q34009618-03711690-B32A-46BA-95ED-F41D07B5BD70

Q34009618-0A537571-816B-49CD-B227-8324A35699C4

Q34009618-12800666-6953-48AE-98AD-0A4463B6B17B

Q34009618-15787395-9099-456C-B721-DED76BA182C9

Q34009618-188FAE96-7DE5-4770-9C1E-5241FFFCF482

Q34009618-1EAB1299-39AF-4B05-9AC8-DD7AA0E44D0C

Q34009618-1F33E9B1-5B06-4760-81FD-5738651C27F7

Q34009618-2CD59BFE-EA6D-4B0F-BC72-9FC1DE757F08

Q34009618-30DA6CFF-8923-450F-BEB1-D894D4BDAB3F

Q34009618-31224FAB-B2BE-445A-A604-CD04894FC2B0

P304

Q34009618-782580FE-A46C-4841-A98A-F5BCEF528257

P31

Q34009618-4FD00C62-EE01-44C1-8D97-D788E3EFB5EE

P356

Q34009618-63B18940-9B74-4EF1-A2DE-094C6779870B

P433

Q34009618-1C36AA59-D9C2-47BF-8F1D-0CFC0BDA86C1

P478

Q34009618-A207F815-C042-4C6C-8F32-78CC0F8FB616

P50

Q34009618-1F52BB92-F144-4D6E-B72B-A9B14505CB35

Q34009618-3F3820F5-E60D-4199-8B4F-E3E2B0BF6600

Q34009618-A4A9E197-C123-44B3-9462-A1EF317F9B93

P577

Q34009618-FD840973-BA63-41FA-8B65-3C311D72EC22

P698

Q34009618-D4B1DCBD-21B8-439D-AB29-0DC73069A49F

P921

Q34009618-E709CC09-423E-4B73-96E6-A0473CDA8839

P932

Q34009618-7DD9084C-EF84-4925-99E1-896566E094B2

P356

P1433

Journal of Alzheimer's Disease

P1476

Reexamining Alzheimer's diseas ...... ein precursor and amyloid-beta

@en

P2093

Akihiko Nunomura

http://www.w3.org/2001/XMLSchema#string

Hyoung-gon Lee

http://www.w3.org/2001/XMLSchema#string

Masao Nakamura

http://www.w3.org/2001/XMLSchema#string

Rudy J Castellani

http://www.w3.org/2001/XMLSchema#string

Sandra L Siedlak

http://www.w3.org/2001/XMLSchema#string

Takaaki Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Functional amyloid formation within mammalian tissue.

Amyloid plaque core protein in Alzheimer disease and Down syndrome

No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

Neuropathological stageing of Alzheimer-related changes

Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms

Sortilin-related receptor with A-type repeats (SORLA) affects the amyloid precursor protein-dependent stimulation of ERK signaling and adult neurogenesis

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Copernicus revisited: amyloid beta in Alzheimer's disease.

P304

447-452

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2009-1151

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Mark Anthony Smith

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19584435

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2907530

http://www.w3.org/2001/XMLSchema#string